Merck wins Apotex injunction over Nasonex
Merck Sharp & Dohme has won an injunction in Australia preventing generic rival Apotex from selling a range of nasal sprays alleged to infringe the IP rights in Merck’s Nasonex product
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: